Basiliximab, Daclizumab - BlackBoxRX.com

Basiliximab, Daclizumab

Should be administered under qualified medical supervision(a physician experienced in immunosuppression therapy and management of organ transplant).
Should be administered in equipped facility with supportive medical and laboratory resources
The physician responsible for drug administration should have complete information requisite for the follow-up of the patient

Package Inserts

Updated July 2009

Disclaimer: This information presents a SUMMARY of Black Box data from product information labeling and does not address additional warnings, precautions, or other important safety data in the product insert. Patient care decisions SHOULD NOT be made without reviewing the most recent product information insert, which may be obtained from the manufacturer. This table may not be complete as it was prepared using product information from package inserts. It is periodically updated with supplemental information from FDA safety alerts, the FDA labeling announcements, and new drug approvals.

Formweb is a product of Formulary Productions, LLC. Visit our website at www.formweb.com for more information on online formularies featuring Black Box Warnings.
901-767-3000